FDA Inspection 1174998 — Aspen Notre Dame de Bondeville
The FDA completed an inspection of Aspen Notre Dame de Bondeville on April 16, 2021 in Notre-Dame-De-Bondeville. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 16, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Notre-Dame-De-Bondeville (France)
Additional Details
Mutual Recognition Agreement (MRA)